Rafivirumab, CAS 944548-37-2

Product Description: Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails[1][2][3].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Kramer RA, et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol. 2005 Jul;35(7):2131-45. /[2]Franka R, et al. In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants. Trop Med Infect Dis. 2017 Sep 20;2(3):48. /[3]Ejemel M, et al. A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Sci Rep. 2022 Jun 7;12(1):9403.

CAS Number: 944548-37-2

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: 10 mM in DMSO

Target: RABV

• SKU: MEXHY-P99811-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99811-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated